Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06174428 · ClinicalTrials.gov registry record
Validity of Viome's Oral/throat Cancer Test
A clinical trial of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma, sponsored by Viome.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT06174428: Recruiting study of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma, sponsored by Viome.
NCT06174428 is a study of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma that is actively recruiting participants, run by Viome. The registered enrollment target is 1,000 participants, above the 145-participant average among 14 other Oropharyngeal Squamous Cell Carcinoma trials with a reported enrollment target (590% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06174428, a study of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma, is actively recruiting participants, sponsored by Viome.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patients.
Primary Outcome
Oral/Throat cancer test's ability to designate an individual with disease as positive
Conditions Studied
Interventions
- DEVICE Oral/Throat cancer test
Study Locations (2)
Missouri
- Missouri School of Dentistry & Oral Health - St Louis
Tennessee
- UTHSC - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-12 |
What NCT06174428 shows while recruiting
NCT06174428 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 145-participant average among 14 other Oropharyngeal Squamous Cell Carcinoma trials with a reported enrollment target (590% higher).
The record links to 3 conditions, with Oropharyngeal Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Oral/Throat cancer test is the first listed.
NCT06174428 reports a single indexed study location in Missouri, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06174428 about?
NCT06174428 is a clinical study titled "Validity of Viome's Oral/throat Cancer Test". A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patien...
What is the current status of trial NCT06174428?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-01-27. Estimated completion is 2026-12.
What conditions does trial NCT06174428 study?
This clinical trial studies the following conditions: Oropharyngeal Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma, Oral and Throat Cancer.
What interventions are being tested in trial NCT06174428?
The interventions under investigation include: Oral/Throat cancer test (DEVICE).
Who is sponsoring clinical trial NCT06174428?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06174428 being conducted?
This trial has 2 study locations across Missouri, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oropharyngeal Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06174428's enrollment target sits among peer trials
1,000 1st of 14 higher than 14 of 14 other Oropharyngeal Squamous Cell Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oropharyngeal Squamous Cell Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
RECRUITING · Phase 2
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
RECRUITING · Phase 2
-
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
RECRUITING
-
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
RECRUITING · Early Phase 1
-
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
RECRUITING · Phase 2
-
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI